Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
Authors:
- 2 December 2019
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 73 (1) , 39-58
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder, marked by cortical and hippocampal deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles and cognitive impairment. Studies indicate a prominent link between cerebrovascular abnormalities and the onset and progression of AD, where blood-brain barrier (BBB) dysfunction and metabolic disorders play key risk factors. Pericyte degeneration, endothelial cell damage, astrocyte depolarization, diminished tight junction integrity, and basement membrane disarray trigger BBB damage. Subsequently, the altered expression of low-density lipoprotein receptor-related protein 1 and receptor for advanced glycation end products at the microvascular endothelial cells dysregulate Aβ transport across the BBB. White matter lesions and microhemorrhages, dyslipidemia, altered brain insulin signaling, and insulin resistance contribute to tau and Aβ pathogenesis, and oxidative stress, mitochondrial damage, inflammation, and hypoperfusion serve as mechanistic links between pathophysiological features of AD and ischemia. Deregulated calcium homeostasis, voltage gated calcium channel functioning, and protein kinase C signaling are also common mechanisms for both AD pathogenesis and cerebrovascular abnormalities. Additionally, APOE polymorphic alleles that characterize impaired cerebrovascular integrity function as primary genetic determinants of AD. Overall, the current review enlightens key vascular risk factors for AD and underscores pathophysiologic relationship between AD and vascular dysfunction.Keywords
This publication has 172 references indexed in Scilit:
- Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?Trends in Pharmacological Sciences, 2011
- Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Experimental Gerontology, 2011
- Linking lipids to Alzheimer's disease: cholesterol and beyondNature Reviews Neuroscience, 2011
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer DiseaseArchives of Neurology, 2010
- Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohortAnnals of Neurology, 2010
- The dysregulation of intracellular calcium in Alzheimer diseaseCell Calcium, 2010
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2009
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003